A PHASE I, SINGLE-CENTER, MIXED METHODS STUDY ON THE HEALTH OUTCOMES OF VISUAL SELF EXPRESSION
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 18 - 70 |
| Updated: | 5/17/2017 |
| Start Date: | May 15, 2017 |
| End Date: | December 15, 2018 |
| Contact: | William Levin, MD |
| Email: | PennCancerTrials@emergingmed.com |
| Phone: | 855-216-0098 |
To gain understanding about the impact of visual art making on biomarkers, such as cortisol,
alpha amylase, oxytocin, etc. to examine whether and to what extent there are changes in
levels of stress and immune function in patients and caregivers adults (including family
caregivers and medical professionals)
alpha amylase, oxytocin, etc. to examine whether and to what extent there are changes in
levels of stress and immune function in patients and caregivers adults (including family
caregivers and medical professionals)
Inclusion Criteria:
- Adults between the age of 18 - 70
- A healthcare professional, a patient or caregiver in the Radiation Oncology
Department at the University of Pennsylvania
- Subjects must be capable of giving informed consent
Exclusion Criteria:
- Any healthcare professional or patient/caregiver not working in or being seen at
Radiation Oncology Department at the University of Pennsylvania
We found this trial at
1
site
3400 Civic Center Blvd
Philadelphia, Pennsylvania 19104
Philadelphia, Pennsylvania 19104
(215) 662-6065
Phone: 855-216-0098
Abramson Cancer Center of the University of Pennsylvania The Abramson Cancer Center of the University...
Click here to add this to my saved trials
